Peptides,GLP-1,GIP,Simeglutide,Semaglutide,Tirzepatide,Liraglutide,Retatrutide,Acetyl hexapeptide,Leuprorelin Acetate

Liraglutide

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults with type 2 diabetes mellitus, and an anti-obesity medication used for long-term weight management, and to reduce the risk of heart attack, stroke and CV death in adults with type 2 diabetes and established CV disease.

Product Name: Liraglutide

CAS: 204656-20-2

Formulation: C172H265N43O51

Package: at customer requirement

Storage: 2-8°C

Shippment：Air shipping

Send Email

Chat Now

Share With:

Product Classification

Sterile Vial

Sterile vacuum vial

Ready to use products

Pharmaceutical packaging

Peptides

Chromatography Consumables

Phone: +86 18892696988

E-mail: info@steriscience.net

E-mail: sales@steriscience.net

Add:Block C, Building 35, Tanjing Commercial Center, Baiyun Street, Kecheng District, Quzhou City, Zhejiang Province, China

Product Description

Product name: Liraglutide
CAS: 204656-20-2
Storage: 2-8°C
Package：1mg/bottle, 5mg/bottle ,10mg/bottle,or at customer requirement
Delivery term：2-3Weeks
Shippment：Air shipping
Formulation: C172H265N43O51
After-sale technical servives provided
Customers' commercial secrets absolutely protected
For research purposes

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults with type 2 diabetes mellitus, and an anti-obesity medication used for long-term weight management, and to reduce the risk of heart attack, stroke and CV death in adults with type 2 diabetes and established CV disease.